GlassScriptPhysician profile
Timothy Treloar
NPI 1730771528
$3,581.04
in general payments reported to CMS, 2019-2025
19 companies · $1,320 in 2025
The $1,320 reported for 2025 was more than what 93% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $927 · 2022: $771 · 2023: $382 · 2024: $181 · 2025: $1,320.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,047 · Food and Beverage: $836.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,046.85 |
| Food and Beverage | $836.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $1,210.15 | 2025 | Venapax |
| Terumo Cardiovascular Systems Corporation | $755.48 | 2021 | |
| Atricure, INC. | $583.74 | 2022-2025 | Synergy Ablation System, Atricure Cryoice Cryoablation System (Cryo2), Atriclip Laa Exclusion System |
| Getinge USA Sales, LLC | $354.01 | 2022 | |
| Abiomed | $125.00 | 2023 | Impella |
| W. L. Gore & Associates, INC. | $107.45 | 2024-2025 | Gore Tag Thoracic Branch Endoprosthesis, Gore Tag Conformable Thoracic Endoprosthesis |
| Silk Road Medical, INC. | $94.74 | 2021 | |
| Lsi Solutions INC | $72.92 | 2022 | |
| Amarin Pharma, INC. | $44.00 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $42.33 | 2023 | Tagrisso |
| Edwards Lifesciences Corporation | $33.84 | 2024 | Hemosphere |
| Angiodynamics, INC. | $26.57 | 2022 | |
| Convatec INC. | $23.45 | 2022 | |
| Becton, Dickinson and Company | $22.14 | 2024 | Progel Applicator Spray Tips |
| La Jolla Pharmaceutical Company | $21.96 | 2025 | Giapreza |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $18.70 | 2021 | |
| Chiesi USA, INC. | $16.80 | 2022 | |
| Medtronic, INC. | $14.03 | 2023 | Illumisite |
| Janssen Pharmaceuticals, INC | $13.73 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Treloar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.